Characteristic biological activities of lipopolysaccharides from Sinorhizobium and Mesorhizobium

Journal of Endotoxin Research

Volumn 10, Issue 1, 2004, Pages 25-31

  Tsukushi, Yasuyo ^a,b   Kido, Nobuo ^a   Saeki, Kazuhiko ^c   Sugiyama, Tsuyoshi ^b   Koide, Naoki ^b   Mori, Isamu ^b   Yoshida, Tomoaki ^b   Yokochi, Takashi ^b  

^a NAGOYA UNIVERSITY   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Lipid A; LPS; Mesorhizobium; Rhizobium; Sinorhizobium

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; LIPID A; NITRIC OXIDE; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG BINDING; ESCHERICHIA COLI; FEMALE; HUMAN; LETHALITY; LIMULUS LYSATE TEST; LIPID ANALYSIS; MALE; MESORHIZOBIUM LOTI; MOUSE; NONHUMAN; PROTEIN SYNTHESIS; RHIZOBIUM; SINORHIZOBIUM MELILOTI; STATISTICAL SIGNIFICANCE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BIOLOGICAL ASSAY; ESCHERICHIA COLI; HORSESHOE CRABS; LIPOPOLYSACCHARIDES; NITRIC OXIDE; PROTEOBACTERIA; SINORHIZOBIUM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI; LIMULUS; MESORHIZOBIUM; MESORHIZOBIUM LOTI; RHIZOBIUM; SINORHIZOBIUM; SINORHIZOBIUM MELILOTI;

EID: 1842636650     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805104225003799     Document Type: Article

References (31)

1. Spaink HP. Root nodulation and infection factors produced by rhizobial bacteria. Annu Rev Microbiol 2000; 54: 257-288.
2. Denarie J, Debelle F, Prome JC. Rhizobium lipochitooligosaccharide nodulation factors: Signaling molecules mediating recognition and morphogenesis. Annu Rev Biochem 1996; 65: 503-535.
3. Loppnow H, Libby P, Freudenberg M, Krauss JH, Weckesser J, Mayer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 1990; 58: 3743-3750.
4. Urbanik-Sypniewska T, Choma A, Kutkowska J et al. Cytokine inducing activities of rhizobial and mesorhizobial lipopolysaccharides of different lethal toxicity. Immunobiology 2000; 202: 408-420.
5. Westphal O, Jann K. Bacterial lipopolysaccharides-extraction with phenol water and further application of the procedure. Methods Carbohydr Chem 1965; 5: 83-91.
6. Yokochi T, Inoue Y, Yokoo J, Kimura Y, Kato N. Retention of bacterial lipopolysaccharide at the side of subcutaneous injection. Infect Immun 1989; 57: 1786-1791.
7. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 1983; 154: 269-277.
8. 15N nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
9. Yokochi T, Inoue Y, Kimura Y, Kato N. Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with complement and its relation to adjuvant action. J Immunol 1990; 144: 3106-3110.
10. Morrison DC, Jacobs DM. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 1976; 13: 813-818.
11. Jacobs DM, Morrison DC. Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. J Immunol 1977; 118: 21-27.
12. Peterson AA, Fesik SW, McGroarty EJ. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother 1987; 31: 230-237.
13. Rana FR, Blazyk J. Interactions between the antimicrobial peptide, magainin 2, and Salmonella typhimurium lipopolysaccharides. FEBS Lett 1991; 293: 11-15.
14. Galanos C, Freudenberg MA, Katschinski T, Salomao R, Mossmann H, Kumazawa Y. Tumor necrosis factor and host response to endotoxin, In: Ryan JL, Morrison DC. (eds) Bacterial Endotoxic Lipopolysaccharides, Vol. 2. Boca Raton, FL: CRC Press, 1992; 75-104.
15. Lehman V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987; 163: 657-663.
16. Freudenberg MA, Galanos C. Interaction of lipopolysaccharides and lipid A with complement in rats and its relation to endotoxicity. Infect Immun 1978; 19: 875-882.
17. Wilson ME, Morrison DC. Evidence for different requirements in physical state for the interaction of lipopolysaccharides with the classical and alternative pathways of complement. Eur J Biochem 1982; 128: 137-141.
18. Vukajlovich SW. Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A. Infect Immun 1986; 53: 480-485.
19. Vukajlovich SW, Hoffman J, Morrison DC. Activation of human serum complement by bacterial lipopolysaccharides: Structural requirements for antibody independent activation of the classical and alternative pathways. Mol Immunol 1987; 24: 319-331.
20. Jiang GZ, Sugiyama T, Kato Y, Koide N, Yokochi T. Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation. Infect Immun 1995; 63: 2537-2540.
21. Dierich MP, Bitter-Suermann D, Konig W, Hadding U, Galanos C, Rietschel ET. Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology 1973; 24: 721-731.
22. Galanos C, Luderitz O. The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anticomplementary activity. Eur J Biochem 1976; 65: 403-408.
23. Morrison DC, Kline LF. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol 1977; 118: 362-368.
24. 2-lipid IVA. J Bacteriol 1994; 176: 4646-4655.
25. Russa R, Urbanik-Sypniewska T, Lindstrom K, Mayer H. Chemical characterization of two lipopolysaccharide species isolated from Rhizobium loti NZP2213. Arch Microbiol 1995; 163: 345-351.
26. Kannenberg EL, Carlson RW. Lipid A and O-chain modifications cause Rhizobium lipopolysaccharides to become hydrophobic during bacteroid development. Mol Microbiol 2001; 39: 379-391.
27. Bhat UR, Forsberg LS, Carlson RW. Structure of lipid A component of Rhizobium leguminosarum bv. phaseoli lipopolysaccharide. Unique nonphosphorylated lipid A containing 2-amino-2-deoxygluconate, galacturonate, and glucosamine. J Biol Chem 1994; 269: 14402-14410.
28. Schromm AB, Brandenburg K, Loppnow H et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem 2000; 267: 2008-2013.
29. Schromm AB, Brandenburg K, Loppnow H et al. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol 1998; 161: 5464-5471.
30. Pollack M, Ohl CA. Endotoxin-based molecular strategies for the prevention and treatment of Gram-negative sepsis and septic shock: pathology of septic shock. Curr Top Microbiol Immunol 1996; 216: 275-297.
31. Heumann D, Glauser MP. Anticytokine strategies for the treatment of septic shock: Relevance of animal models. Curr Top Microbiol Immunol 1996; 216: 299-309.